Klöbl, Manfred http://orcid.org/0000-0003-2107-8803
Reed, Murray Bruce
Handschuh, Patricia
Kaufmann, Ulrike
Konadu, Melisande Elisabeth
Ritter, Vera
Spurny-Dworak, Benjamin
Kranz, Georg S.
Lanzenberger, Rupert http://orcid.org/0000-0003-4641-9539
Spies, Marie
Clinical trials referenced in this document:
Documents that mention this clinical trial
Gender Dysphoria and Sexual Euphoria: A Bayesian Perspective on the Influence of Gender-Affirming Hormone Therapy on Sexual Arousal
https://doi.org/10.1007/s10508-023-02778-1
Funding for this research was provided by:
Austrian Science Fund (KLI 504, KLI 516)
Brain and Behavior Research Foundation (23741)
Bundesministerium für Wissenschaft, Forschung und Wirtschaft (Interdisciplinary translational brain research cluster (ITHC) with highfield MR)
Österreichischen Akademie der Wissenschaften (DOC, DOC)
Medical University of Vienna
Article History
Received: 17 February 2022
Revised: 1 December 2023
Accepted: 6 December 2023
First Online: 12 January 2024
Declarations
:
: Rupert Lanzenberger received travel grants and/or conference speaker honoraria within the last three years from Bruker BioSpin MR and Heel and has served as a consultant for Ono Pharmaceutical. He received investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. Marie Spies received travel grants from Janssen, AOP Orphan Pharmaceuticals; Lecture Honoraria: Heel, Janssen and Austroplant. She further spoke at a workshop organized by Eli Lilly. All other authors have no financial disclosures to state. Preliminary results of the analyses in this work were presented as poster at the 17th Austrian Neuroscience Association meeting in 2021 in Salzburg, Austria. A preprint of this work was published on medRxiv (doi: ExternalRef removedExternalRef removed). All authors reported no biomedical financial interests or potential conflicts of interest.
: This study was conducted according to the Declaration of Helsinki including all current revisions and the good scientific practice guidelines of the Medical University of Vienna. The protocol was approved by the institutional review board (EK Nr.: 1104/2015) and registered at clinicaltrials.gov (NCT02715232).
: Informed consent was obtained from all individual participants included in the study.